BUSINESSMAN Dennis Stewart is fronting his own distributorship to market medication which helped overcome his own debilitating back problems.
And the 52-year-old Bury man's belief in the products is evidenced by the fact he paid £3,000 for the licence to supply the capsules throughout the north west.
Dennis was so impressed by the Col-Eaze medication that he has launched his own Palever Services company to sell the product throughout the region.
The capsules are collagen-based. Collagen was originally developed for arthritis, helping to rebuild the cartilage in arthritic joints. But pure collagen capsules can treat the condition from the inside out. It's completely natural and collagen is also reported to improve fine lines and wrinkles, hair, nails and energy levels.
Dennis said: "I've purchased the licence from the manufacturers and I'm covering the north west. I'm targeting individuals at the moment, but I'd like to get into the retail side itself."
The businessman is keenly aware of the acute arthritic pain the capsules can help overcome. "I've had back problems for the past 20 years. I had also had a car crash in 1986, which made the condition worse".
Dennis, a trade carpenter-joiner who has worked all over the world, had tried other cures before he became aware of the collagen capsules. In just three months, he says his suffering was eased considerably.
"I get substantial pain relief. It isn't 100 per cent, but the capsules have really helped my back problems," he says. "Once in the system, the collagen relieves a lot of the inflammation and I've also found I've regained much of my old energy. Once the collagen is in the system, it regenerates the collagen that is already there."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article